The impact of oxidative and carbonyl stress on cell function: Functional consequences for macrophages

Lung Macrophages in Health and Disease

Volumn , Issue , 2009, Pages 88-98

  Kirkham, Paul ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952770647     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805020810901010088     Document Type: Chapter

References (80)

1. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006; 111: 476-94.
2. Lovell MA, Markesbery WR. Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Curr Alzheimer Res 2006; 3: 359-364.
3. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-20966.
4. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, et al. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 2006; 372: 147-53.
5. Shah R, Raska Jr K, Tiku ML. The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis. Arthritis Rheum 2005; 52: 2799-2807.
6. Negre-Salvayre A, Coatrieux C, Ingueneau C, et al. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Brit J Pharmacol 2008; 153: 6-20.
7. Dalle-Donne I, Giustarini D, Colombo R, et al. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169-176.
8. Dalle-Donne I, Aldini G, Carini M, et al. Protein carbonylation, cellular dysfunction and disease progression. J Cell Mol Med 2006; 10: 389-406.
9. Meja KK, Rajendrasozhan S, Adenuga D, et al.Rahman I. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 2008; 39: 312-23.
10. Rahman I, Van Schadewijk AA, Crowther AJ, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 490-495.
11. Kirkham PA, Spooner G, Ffoulkes-Jones C, et al. Cigarette Smoke Triggers Macrophage Adhesion and Activation: Role of Lipid Peroxidation Products and Scavenger Receptor. Free Rad Biol Med 2003; 35: 697-710.
12. Witko-Sarsat V., Friedlander M, Nguyen KT, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Immunology 1998; 161: 2524-2532.
13. Meagher LC, Savill JS, Baker A, et al. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukocyte Biol 1992; 52: 269-273.
14. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160: S5-S11.
15. Donaldson K, Brown DM, Mitchell C, et al. Free radical activity of PM10: iron-mediated generation of hydroxyl radicals. Environ Health Perspect 1997; 105: 1285-1289.
16. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111-126.
17. Nakayama T, Church DF, Pryor WA. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Rad Biol Med 1989; 7: 9-15.
18. Zang LY, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Rad Biol Med 1995; 19: 161-167.
19. Rochelle LG, Fischer BM, Adler KB. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Rad Biol Med 1998; 24: 863-868.
20. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
21. Ghio AJ, Pritchard RJ, Dittrich KL, et al. Non-heme (Fe3+) in the lung increases with age in both humans and rats. J Lab Clin Med 1997; 129: 53-61.
22. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828.
23. Esterbauer H. Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med (1991) 11, 81-128.
24. Poli G, Leonarduzzi G, Biasi F, et al. Oxidative stress and cell signaling. Curr Med Chem 2004; 11: 1163-1182.
25. Cerami C, Founds H, Nicholl I, et al.Tobacco smoke is a source of toxic reactive glycation products. Proc Nat Acad Sci USA 1997; 94: 13915-13920.
26. Reznick AZ, Cross CE, Hu ML, et al. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J 1992; 286: 607-611.
27. Parola M, Bellomo G, Robino G, et al. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antiox Redox Signal 1999; 1: 255-284.
28. Uchida K, Shiraishi M, Naito Y, et al. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999; 274: 2234-2242.
29. Refsgaard HH, Tsai L, Stadtman ER. Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc Nat Acad Sci USA. 2000; 97: 611-616.
30. Uchida K, Kanematsu M, Sakai K, et al. Protein-bound acrolein: potential markers for oxidative stress. Proc Nat Acad Sci USA. 1998; 95: 4882-4887.
31. Lander HM, Hajjar DP, Hempstead BL, et al. A Molecular Redox Switch on P21(Ras). Structural Basis for the Nitric Oxide-P21(Ras) Interaction. J Biol Chem 1997; 272: 4323-4326.
32. Saitoh M, Nishitoh H, Fujii M, et al. Mammalian Thioredoxin Is a Direct Inhibitor of Apoptosis Signal-Regulating Kinase (ASK) 1. EMBO J 1998; 17: 2596-2606.
33. Kamata H, Honda S, Maeda S, et al. Reactive Oxygen Species Promote TNFalpha-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases. Cell 2005; 120: 649-661.
34. Sun Y, Oberley LW. Redox Regulation of Transcriptional Activators. Free Radic Biol Med 1996; 21: 335-348.
35. Datta K, Babbar P, Srivastava T, et al. P53 Dependent Apoptosis in Glioma Cell Lines in Response to Hydrogen Peroxide Induced Oxidative Stress. Int J Biochem Cell Biol 2002); 34: 148-157.
36. Huang RP, Peng A, Hossain MZ, et al. Tumor Promotion by Hydrogen Peroxide in Rat Liver Epithelial Cells. Carcinogenesis 1999; 20: 485-492.
37. Andrews GK. Regulation of Metallothionein Gene Expression by Oxidative Stress and Metal Ions. Biochem Pharmacol 2000; 59: 95-104.
38. Okamoto K, Tanaka H, Ogawa H, et al. Redox-Dependent Regulation of Nuclear Import of the Glucocorticoid Receptor. J Biol Chem 1999; 274: 10363-10371.
39. Ichiki T, Tokunou T, Fukuyama K, et al. Cyclic AMP Response Element-Binding Protein Mediates Reactive Oxygen Species-Induced C-Fos Expression. Hypertension 2003; 42 : 177-183.
40. Thannickal VJ, Fanburg BL. Reactive Oxygen Species in Cell Signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-L1028.
41. Chen ZH, Saito Y, Yoshida Y, et al. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005; 280: 41921-41927.
42. Sampey BP, Carbone DL, Doorn JA, et al. 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction. Mol Pharmacol 2007; 71: 871-883.
43. Soh Y, Jeong KS, Lee IJ, et al. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol Pharmacol 2000; 58: 535-541.
44. Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004; 37: 937-945.
45. Leonarduzzi G, Robbesyn F, Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004; 7: 1694-1702.
46. Je JH, Lee JY, Jung KJ, et al. NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett 2004; 566: 183-189.
47. Ji, C, Kozak KR, Marnett LJ. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem 2001; 276: 18223-18228.
48. Castello L, Marengo B, Nitti M, et al. 4-Hydroxynonenal signaling to apoptosis in isolated rat hepatocytes: the role of PKC-delta. Biochim Biophys Acta (.2005; 1737: 83-93.
49. Carbone DL, Doorn JA, Kiebler Z, et al. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 2005; 315: 8-15.
50. England K, Cotter T. Identification of carbonylated proteins by MALDI-TOF mass spectroscopy reveals susceptibility of ER. Biochem Biophys Res Commun 2004; 320: 123-30.
51. Grune T, Davies KJ. The proteasomal system and HNE-modified proteins. Mol Aspects Med 2003; 24: 195-204.
52. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 2003; 228: 111 - 133.
53. Marwick JA, Kirkham PA, Stevenson CS, et al.Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Resp Cell. Mol Biol 2004; 31: 633-642.
54. Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004; 68: 1255-1267.
55. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000; 20: 6891-6903.
56. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008; 7: 567-73.
57. Levonen AL, Landar A, Ramachandran A, et al. Cellular mechanisms of redox cell signaling: role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 2004; 378: 373-82.
58. Platt N. Gordon S. Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands. Chem Biol 1998; 5: R193-R203.
59. El-Khoury J, Thomas CA, Loike JD, et al.Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem 1994; 269: 10197-10200.
60. Maxeiner H, Husemann J, Thomas CA, et al.Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with low-density lipoproteins and in secretion of H2O2. J Exp Med 1998; 188: 2257-2265.
61. El Khoury J, Hickman SE, Thomas CA, et al. Scavenger receptor-mediated adhesion of microglia to betaamyloid fibrils. Nature 1996; 382: 716-719.
62. Fraser I, Hughes D, Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993; 364: 343-346.
63. Stevenson CS, Docx C, Webster R, et al.Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1183-93.
64. Hersh CP, DeMeo DL, Raby BA, et al. Genetic linkage and association analysis of COPD-related traits on chromosome 8p. COPD 2006; 3:189-94.
65. Alford PB, Xue Y, Thai SF, et al. Maleylated-BSA enhances production of nitric oxide from macrophages. Biochem Biophys Res Commun 1998; 245: 185-9.
66. Misra UK, Shackelford RE, Florine-Casteel K, et al.Maleylated-BSA induces hydrolysis of PIP2, fluxes of Ca2+, NF-kappaB binding, and transcription of the TNF-alpha gene in murine macrophages. J Leukoc Biol 1996; 60: 784-92.
67. Yamada Y, Doi T, Hamakubo T, et al. Scavenger receptor family proteins: roles for atherosclerosis, host defense and disorders of the central nervous system. Cell Mol Life Sci 1998; 54: 628-40.
68. Adiguzel E, Ahmad PJ, Franco C, et al. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14: 73-89.
69. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-8.
70. Ferrara F, D'Adda D, Falchi M, et al. The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease. Int J Tissue React 1996; 18: 109-114.
71. Calingasan NY, Uchida K, Gibson GE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 1999; 72: 751-6.
72. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352: 1967-76.
73. Schmidt AM, Yan SD, Brett J, et al. Regulation of human mononuclear phagocyte migration by cell surfacebinding proteins for advanced glycation end products. J Clin Invest 1993; 91: 2155-68.
74. Kirkham PA, Spooner G, Rahman I, et al. Macrophage Phagocytosis of Apoptotic Neutrophils Is Compromised by Matrix Proteins Modified by Cigarette Smoke and Lipid Peroxidation Products. Biochem Biophys Res Commun 2004; 318: 32-37.
75. Allison ME, Fearon DT. Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity. Eur J Immunol 2000; 30: 2881-7.
76. Eggleton P, Haigh R, Winyard PG. Consequence of neo-antigenicity of the 'altered self'. Rheumatology (Oxford) 2008; 47: 567-71.
77. Agustí A, MacNee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-4.
78. van der Strate BW, Postma DS, Brandsma CA, et al. Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 2006; 173: 751-8.
79. Lee SH, Goswami S, Grudo A, et al.Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13: 567-9.
80. Aldini G, Dalle-Donne I, Facino RM, et al. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev 2007; 27: 817-68.